Inventor · disambiguated record
Wenyan Shen
Also filed as: SHEN WENYAN
49 granted patents·22 pending applications·1,344 citations·filing 1991–2025
99Inventor score
Files withAMGEN INC31NGM BIOPHARMACEUTICALS INC20JACKSON SIMON MARK9LI JI2BAOLI TIANTONG INSTR CORP1
Top patents by PatentIndex Score
71 records- 0199US8859741B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Oct 14, 2014·51 cites·24 claims
- 0299US8829165B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2013·Granted Sep 9, 2014·76 cites·29 claims
- 0399US8030457B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2008·Granted Oct 4, 2011·175 cites·27 claims
- 0499US7915391B2Humanized c-Kit antibodyAMGEN INC·Filed 2007·Granted Mar 29, 2011·112 cites·10 claims
- 0598US8883983B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Nov 11, 2014·26 cites·30 claims
- 0698US8871914B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Oct 28, 2014·26 cites·25 claims
- 0798US8871913B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Oct 28, 2014·26 cites·29 claims
- 0898US8563698B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)JACKSON SIMON MARK·Filed 2009·Granted Oct 22, 2013·72 cites·6 claims
- 0998US8168762B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)JACKSON SIMON MARK·Filed 2011·Granted May 1, 2012·101 cites·22 claims
- 1097US9056915B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Jun 16, 2015·20 cites·23 claims
- 1197US9045547B2Methods of using antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)JACKSON SIMON MARK·Filed 2011·Granted Jun 2, 2015·42 cites·66 claims
- 1297US8981064B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Mar 17, 2015·20 cites·29 claims
- 1397US8889834B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Nov 18, 2014·25 cites·20 claims
- 1497US7872106B2Sclerostin-binding antibodiesAMGEN INC·Filed 2008·Granted Jan 18, 2011·86 cites·25 claims
- 1596US10174119B2Binding proteins and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2017·Granted Jan 8, 2019·10 cites·43 claims
- 1696US7592429B2Sclerostin-binding antibodyUCB SA·Filed 2006·Granted Sep 22, 2009·166 cites·5 claims
- 1795US9920118B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Mar 20, 2018·19 cites·34 claims
- 1895US9738716B2Beta klotho binding proteins and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Aug 22, 2017·9 cites·6 claims
- 1995US8791249B2Nucleic acid encoding humanized c-kit antibodyAMGEN INC·Filed 2013·Granted Jul 29, 2014·21 cites·6 claims
- 2095US7709611B2Antibodies to Dkk-1AMGEN INC·Filed 2005·Granted May 4, 2010·50 cites·24 claims
- 2194US8436150B2Humanized C-kit antibodyNG GORDON·Filed 2011·Granted May 7, 2013·29 cites·15 claims
- 2294US7868140B2Human anti-B7RP1 neutralizing antibodiesAMGEN INC·Filed 2006·Granted Jan 11, 2011·33 cites·39 claims
- 2393US10093735B2Beta-klotho binding proteinsNGM BIOPHARMACEUTICALS INC·Filed 2017·Granted Oct 9, 2018·4 cites·15 claims
- 2493US7884054B2Methods for identifying functional antibodiesAMGEN INC·Filed 2004·Granted Feb 8, 2011·37 cites·5 claims
- 2592US9920134B2Monoclonal antibodies to proprotein convertase subtilisin kexin type 9 (PCSK9)JACKSON SIMON MARK·Filed 2011·Granted Mar 20, 2018·13 cites·17 claims
- 2692US7906625B2Humanized anti-amyloid antibodyAMGEN INC·Filed 2006·Granted Mar 15, 2011·47 cites·22 claims
- 2789US11530260B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·2 cites·44 claims
- 2889US10744191B2Beta klotho-binding proteins and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted Aug 18, 2020·3 cites·28 claims
- 2988US10800843B2Beta klotho-binding proteinsNGM BIOPHARMACEUTICALS INC·Filed 2016·Granted Oct 13, 2020·3 cites·14 claims
- 3088US10562965B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted Feb 18, 2020·5 cites·39 claims
- 3187US10975154B2Binding proteins and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted Apr 13, 2021·2 cites·56 claims
- 3287US2025188174A1Binding proteins and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3386US11596676B2Methods of treating nonalcoholic steatohepatitis comprising administering an anti-human beta klotho antibody or binding fragment thereofNGM BIOPHARMACEUTICALS INC·Filed 2020·Granted Mar 7, 2023·1 cites·21 claims
- 3486US10995145B2Antibodies which bind human glucagon receptorNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted May 4, 2021·2 cites·29 claims
- 3586US8101184B2Treatment methods using Dkk-1 antibodiesLI JI·Filed 2009·Granted Jan 24, 2012·8 cites·34 claims
- 3685US11667708B2Anti-human beta klotho antibody or binding fragment thereof and methods of their useNGM BIOPHARMACEUTICALS INC·Filed 2020·Granted Jun 6, 2023·1 cites·59 claims
- 3785US9493576B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Nov 15, 2016·2 cites·43 claims
- 3884US12378312B2Polynucleotides encoding human beta klotho antibodies or binding fragments thereof and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2023·Granted Aug 5, 2025·0 cites·23 claims
- 3982US12173060B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2022·Granted Dec 24, 2024·0 cites·23 claims
- 4081US8981071B2Human anti-B7RP1 neutralizing antibodiesSIU GERALD·Filed 2010·Granted Mar 17, 2015·7 cites·41 claims
- 4178US2024084023A1Glucagon receptor binding proteins and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4276US12180289B2Binding proteins and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2021·Granted Dec 31, 2024·0 cites·20 claims
- 4373US11732049B2Methods of reducing or lowering blood glucose levels in a human subject by administering an antibody that specifically binds human glucagon receptorNGM BIOPHARMACEUTICALS INC·Filed 2021·Granted Aug 22, 2023·0 cites·24 claims
- 4473US10072090B2Human anti-B7RP1 neutralizing antibodiesAMGEN INC·Filed 2016·Granted Sep 11, 2018·1 cites·12 claims
- 4572US9266945B2Human anti-B7RP1 neutralizing antibodiesAMGEN INC·Filed 2013·Granted Feb 23, 2016·1 cites·29 claims
- 4672US2015031870A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)AMGEN INC·Filed 2014·Application pending·0 cites
- 4771US2015087819A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)AMGEN INC·Filed 2014·Application pending·0 cites
- 4870US8992925B2RANKL antibody-PTH/PTHrP chimeric moleculesKOSTENUIK PAUL·Filed 2006·Granted Mar 31, 2015·2 cites·62 claims
- 4967US2025346662A1Homogeneous antibody populationsAMGEN INC·Filed 2025·Application pending·0 cites
- 5066US2013058944A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)AMGEN INC·Filed 2012·Application pending·0 cites
Showing the top 50 of 71 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Wenyan Shen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →